Roles of liver fluke infection as risk factor for cholangiocarcinoma

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 21, Issue 5, 2014, Pages 301-308

  Sithithaworn, Paiboon ^a   Yongvanit, Puangrat ^a   Duenngai, Kunyarat ^a,b   Kiatsopit, Nadda ^a   Pairojkul, Chawalit ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b PHETCHABUN RAJABHAT UNIVERSITY   (Thailand)

Author keywords

Cholangiocarcinoma; Liver cancer; Liver fluke; Opisthorchis viverrini; Thailand

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BILE DUCT CARCINOMA; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CARCINOGENICITY; FASCIOLA HEPATICA; FASCIOLIASIS; GEOGRAPHIC DISTRIBUTION; HEALTH EDUCATION; HEPATOBILIARY DISEASE; HOST PARASITE INTERACTION; HUMAN; INFECTION CONTROL; LIFE CYCLE ASSESSMENT; MASS BEHAVIOR; NONHUMAN; OPISTHORCHIS VIVERRINI; PARASITE PREVALENCE; PRIMARY PREVENTION; RISK FACTOR; THAILAND; TREND STUDY; ANIMAL; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; CLONORCHIS SINENSIS; INCIDENCE; INTRAHEPATIC BILE DUCT; OPISTHORCHIS; PARASITOLOGY; PREVALENCE; TREMATODE INFECTIONS;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CLONORCHIS SINENSIS; HUMANS; INCIDENCE; OPISTHORCHIS; PREVALENCE; RISK FACTORS; THAILAND; TREMATODE INFECTIONS;

EID: 84898967854     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1002/jhbp.62     Document Type: Article

References (71)

1. Gatto M, Bragazzi MC, Semeraro R, Napoli C, Gentile R, Torrice A, et al. Cholangiocarcinoma: update and future perspectives. Dig Liver Dis. 2010; 42: 253-260.
2. Olnes MJ, Erlich R,. A review and update on cholangiocarcinoma. Oncology. 2004; 66: 167-179. (Pubitemid 38813042)
3. Patel T,. Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol. 2006; 3: 33-42. (Pubitemid 43102075)
4. Attasara P, Sriplung H,. Cancer incidence in Thailand. In:, Khuhaprema T, Attasara P, Sriplung H, Wiangnon S, Sumitsawan Y, Sangrajrang S, editors. Cancer in Thailand. Vol. VI, 2004-2006. Bangkok: Ministry of Public Health, Ministry of Education; 2012. p. 3-68.
5. Tyson GL, El-Serag HB,. Risk factors for cholangiocarcinoma. Hepatology. 2011; 54: 173-184.
6. Wadsworth CA, Westaby D, Khan SA,. Endoscopic radiofrequency ablation for cholangiocarcinoma. Curr Opin Gastroenterol. 2013; 29: 305-311.
7. Keiser J, Utzinger J,. Food-borne trematodiases. Clin Microbiol Rev. 2009; 22: 466-483.
8. Sithithaworn P, Andrews RH, Nguyen VD, Wongsaroj T, Sinuon M, Odermatt P, et al. The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitol Int. 2012; 61: 10-16.
9. Pozio E, Armignacco O, Ferri F, Gomez Morales MA,. Opisthorchis felineus, an emerging infection in Italy and its implication for the European Union. Acta Trop. 2013; 126: 54-62.
10. Yossepowitch O, Gotesman T, Assous M, Marva E, Zimlichman R, Dan M,. Opisthorchiasis from imported raw fish. Emerg Infect Dis. 2004; 10: 2122-2126.
11. Saijuntha W, Sithithaworn P, Wongkham S, Laha T, Pipitgool V, Tesana S, et al. Evidence of a species complex within the food-borne trematode Opisthorchis viverrini and possible co-evolution with their first intermediate hosts. Int J Parasitol. 2007; 37: 695-703. (Pubitemid 46440943)
12. Andrews RH, Sithithaworn P, Petney TN,. Opisthorchis viverrini: an underestimated parasite in world health. Trends Parasitol. 2008; 24: 497-501.
13. Lai DH, Wang QP, Chen W, Cai LS, Wu ZD, Zhu XQ, et al. Molecular genetic profiles among individual Clonorchis sinensis adults collected from cats in two geographic regions of China revealed by RAPD and MGE-PCR methods. Acta Trop. 2008; 107: 213-216.
14. Lee SU, Huh S,. Variation of nuclear and mitochondrial DNAs in Korean and Chinese isolates of Clonorchis sinensis. Korean J Parasitol. 2004; 42: 145-148.
15. Liu GH, Li B, Li JY, Song HQ, Lin RQ, Cai XQ, et al. Genetic variation among Clonorchis sinensis isolates from different geographic regions in China revealed by sequence analyses of four mitochondrial genes. J Helminthol. 2012; 86: 479-484.
16. Sithithaworn P, Tesana S, Pipitgool V, Kaewkes S, Pairojkul C, Sripa B, et al. Relationship between faecal egg count and worm burden of Opisthorchis viverrini in human autopsy cases. Parasitology. 1991; 102 (Pt 2): 277-281.
17. Petney T, Sithithaworn P, Andrews R, Kiatsopit N, Tesana S, Grundy-Warr C, et al. The ecology of the Bithynia first intermediate hosts of Opisthorchis viverrini. Parasitol Int. 2012; 61: 38-45.
18. Grundy-Warr C, Andrews RH, Sithithaworn P, Petney TN, Sripa B, Laithavewat L, et al. Raw attitudes, wetland cultures, life-cycles: socio-cultural dynamics relating to Opisthorchis viverrini in the Mekong Basin. Parasitol Int. 2012; 61: 65-70.
19. Sithithaworn P, Yongvanit P, Tesana S, Pairojkul C,. Liver flukes. In:, Murrell KD, Bernard F, editors. Food-borne parasitic zoonoses. Berlin: Springer; 2007. p. 3-52.
20. Vichasri S, Viyanant V, Upatham ES,. Opisthorchis viverrini: intensity and rates of infection in cyprinoid fish from an endemic focus in Northeast Thailand. Southeast Asian J Trop Med Public Health. 1982; 13: 138-141. (Pubitemid 12043684)
21. Sithithaworn P, Haswell-Elkins M,. Epidemiology of Opisthorchis viverrini. Acta Trop. 2003; 88: 187-194. (Pubitemid 37377814)
22. Enes JE, Wages AJ, Malone JB, Tesana S,. Prevalence of Opisthorchis viverrini infection in the canine and feline hosts in three villages, Khon Kaen Province, northeastern Thailand. Southeast Asian J Trop Med Public Health. 2010; 41: 36-42.
23. Aunpromma S, Tangkawattana P, Papirom P, Kanjampa P, Tesana S, Sripa B, et al. High prevalence of Opisthorchis viverrini infection in reservoir hosts in four districts of Khon Kaen Province, an opisthorchiasis endemic area of Thailand. Parasitol Int. 2012; 61: 60-64.
24. Upatham ES, Viyanant V, Kurathong S, Rojborwonwitaya J, Brockelman WY, Ardsungnoen S, et al. Relationship between prevalence and intensity of Opisthorchis viverrini infection, and clinical symptoms and signs in a rural community in north-east Thailand. Bull World Health Organ. 1984; 62: 451-461. (Pubitemid 14086593)
25. Haswell-Elkins MR, Elkins DB, Sithithaworn P, Treesarawat P, Kaewkes S,. Distribution patterns of Opisthorchis viverrini within a human community. Parasitology. 1991; 103 (Pt 1): 97-101.
26. Bhamarapravati N, Thammavit W, Vajrasthira S,. Liver changes in hamsters infected with a liver fluke of man, Opisthorchis viverrini. Am J Trop Med Hyg. 1978; 27: 787-794. (Pubitemid 8398085)
27. Haswell-Elkins MR, Sithithaworn P, Mairiang E, Elkins DB, Wongratanacheewin S, Kaewkes S, et al. Immune responsiveness and parasite-specific antibody levels in human hepatobiliary disease associated with Opisthorchis viverrini infection. Clin Exp Immunol. 1991; 84: 213-218.
28. Wongratanacheewin S, Bunnag D, Vaeusorn N, Sirisinha S,. Characterization of humoral immune response in the serum and bile of patients with opisthorchiasis and its application in immunodiagnosis. Am J Trop Med Hyg. 1988; 38: 356-362. (Pubitemid 18086118)
29. Elkins DB, Haswell-Elkins MR, Mairiang E, Mairiang P, Sithithaworn P, Kaewkes S, et al. A high frequency of hepatobiliary disease and suspected cholangiocarcinoma associated with heavy Opisthorchis viverrini infection in a small community in north-east Thailand. Trans R Soc Trop Med Hyg. 1990; 84: 715-719. (Pubitemid 20358593)
30. Mairiang E, Mairiang P,. Clinical manifestation of opisthorchiasis and treatment. Acta Trop. 2003; 88: 221-227. (Pubitemid 37377817)
31. Pairojkul C, Shirai T, Hirohashi S, Thamavit W, Bhudhisawat W, Uttaravicien T, et al. Multistage carcinogenesis of liver-fluke-associated cholangiocarcinoma in Thailand. Princess Takamatsu Symp. 1991; 22: 77-86.
32. Riganti M, Pungpak S, Punpoowong B, Bunnag D, Harinasuta T,. Human pathology of Opisthorchis viverrini infection: a comparison of adults and children. Southeast Asian J Trop Med Public Health. 1989; 20: 95-100.
33. Mairiang E, Elkins DB, Mairiang P, Chaiyakum J, Chamadol N, Loapaiboon V, et al. Relationship between intensity of Opisthorchis viverrini infection and hepatobiliary disease detected by ultrasonography. J Gastroenterol Hepatol. 1992; 7: 17-21.
34. Mairiang E, Haswell-Elkins MR, Mairiang P, Sithithaworn P, Elkins DB,. Reversal of biliary tract abnormalities associated with Opisthorchis viverrini infection following praziquantel treatment. Trans R Soc Trop Med Hyg. 1993; 87: 194-197.
35. Chernrungroj G,. Risk factors for cholangiocarcinoma: a case-control study. New Haven, CT: Yale University; 2000.
36. Sripa B, Mairiang E, Thinkhamrop B, Laha T, Kaewkes S, Sithithaworn P, et al. Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6. Hepatology. 2009; 50: 1273-1281.
37. Mairiang E, Laha T, Bethony JM, Thinkhamrop B, Kaewkes S, Sithithaworn P, et al. Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand. Parasitol Int. 2012; 61: 208-211.
38. Yongvanit P, Pinlaor S, Loilome W,. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2014; 21: 309-15.
39. Bhudhisawasdi V, Khuntikeo N, Chur-in S, Pugkhem A, Talabnin C, Wongkham S,. Cholangiocarcinoma: experience of Srinagarind Hospital. SMJ. 2012; 27: 331-339.
40. Blechacz BR, Gores GJ,. Cholangiocarcinoma. Clin Liver Dis. 2008; 12: 131-150, ix. (Pubitemid 351163138)
41. Khan SA, Toledano MB, Taylor-Robinson SD,. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford). 2008; 10: 77-82. (Pubitemid 351934989)
42. Patel T,. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001; 33: 1353-1357. (Pubitemid 32496970)
43. Shaib Y, El-Serag HB,. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004; 24: 115-125. (Pubitemid 38738341)
44. Gatto M, Alvaro D,. New insights on cholangiocarcinoma. World J Gastrointest Oncol. 2010; 2: 136-145.
45. Sriamporn S, Pisani P, Pipitgool V, Suwanrungruang K, Kamsa-ard S, Parkin DM,. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health. 2004; 9: 588-594. (Pubitemid 38657284)
46. IARC. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon: World Health Organization, International Agency for Research on Cancer; 2011.
47. Attasara P, Srivatanakul P, Sriplung H,. Cancer incidence in Thailand. In:, Khuhaprema T, Srivatanakul P, Sriplung H, Wiangnon S, Sumitsawan Y, Attasara P, editors. Cancer in Thailand. Vol. V, 2001-2003. Bangkok: Ministry of Public Health, Ministry of Education; 2010. p. 3-76.
48. Deerasamee S, Martin N, Sontipong S, Sriamporn S, Sriplung H, Srivatanakul P, et al. Cancer in Thailand. Vol. II, 1992-1994 (IARC Technical Report No. 34). Lyon: International Agency for Research on Cancer; 1999.
49. Khuhaprema T, Srivatanakul P,. Liver and bile duct. In:, Khuhaprema T, Srivatanakul P, Sriplung H, Wiangnon S, Sumitsawan Y, Attasara P, editors. Cancer in Thailand. Vol. IV, 1998-2000. Bangkok: Ministry of Public Health, Ministry of Education; 2007. p. 36-38.
50. Sriamporn S, Jintakanon D, Kamsa-ard S,. Liver. In:, Sriplung H, Sontipong S, Martin N, Wiangnon S, Vootiprux V, Cheirsilpa A, et al., editors. Cancer in Thailand. Vol. III, 1995-1997. Bangkok: National Cancer Institute; 2003. p. 34-37.
51. Vatanasapt V, Martin N, Sriplung H, Chindavijak K, Sontipong S, Sriamporn S, et al. Cancer in Thailand 1988-1991. (IARC Technical Report No. 16). Lyon: International Agency for Research on Cancer; 1993.
52. IARC. Infection with liver flukes (Opisthorchis viverrivi, Opisthorchis felineus and Clonorchis sinensis). IARC Monogr Eval Carcinog Risks Hum. 1994; 61: 121-175.
53. Kurathong S, Lerdverasirikul P, Wongpaitoon V, Pramoolsinsap C, Kanjanapitak A, Varavithya W, et al. Opisthorchis viverrini infection and cholangiocarcinoma. A prospective, case-controlled study. Gastroenterology. 1985; 89: 151-156. (Pubitemid 15057924)
54. Parkin DM, Srivatanakul P, Khlat M, Chenvidhya D, Chotiwan P, Insiripong S, et al. Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma. Int J Cancer. 1991; 48: 323-328.
55. Haswell-Elkins MR, Mairiang E, Mairiang P, Chaiyakum J, Chamadol N, Loapaiboon V, et al. Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int J Cancer. 1994; 59: 505-509. (Pubitemid 24357275)
56. Honjo S, Srivatanakul P, Sriplung H, Kikukawa H, Hanai S, Uchida K, et al. Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand. Int J Cancer. 2005; 117: 854-860. (Pubitemid 41599908)
57. Sripa B, Thinkhamrop B, Mairiang E, Laha T, Kaewkes S, Sithithaworn P, et al. Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini. PLoS Negl Trop Dis. 2012; 6: e1654.
58. Saichua P, Sithithaworn P, Jariwala AR, Deimert DJ, Sithithaworn J, Sripa B, et al. Microproteinuria during Opisthorchis viverrini infection: a biomarker for advanced renal and hepatobiliary pathologies from chronic opisthorchiasis. PLoS Negl Trop Dis. 2013; 7: e2228.
59. Choi D, Lim JH, Lee KT, Lee JK, Choi SH, Heo JS, et al. Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea. J Hepatol. 2006; 44: 1066-1073.
60. Lee TY, Lee SS, Jung SW, Jeon SH, Yun SC, Oh HC, et al. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol. 2008; 103: 1716-1720.
61. Lim MK, Ju YH, Franceschi S, Oh JK, Kong HJ, Hwang SS, et al. Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea. Am J Trop Med Hyg. 2006; 75: 93-96. (Pubitemid 351627576)
62. Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, Choi HC, et al. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol. 1996; 25: 933-940.
63. Cheng Q, Luo X, Zhang B, Jiang X, Yi B, Wu M,. Predictive factors for prognosis of hilar cholangiocarcinoma: postresection radiotherapy improves survival. Eur J Surg Oncol. 2007; 33: 202-207. (Pubitemid 46336554)
64. Liang G, Wen T, Mi K, Li C, Wang C, Li K, et al. Resection of hilar cholangiocarcinoma combined with left hepatectomy and common hepatic arteriectomy without reconstruction. Hepatogastroenterology. 2012; 59: 364-365.
65. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD,. Cholangiocarcinoma. Lancet. 2005; 366: 1303-1314. (Pubitemid 41416587)
66. Khan SA, Thomas HC, Toledano MB, Cox IJ, Taylor-Robinson SD,. p53 Mutations in human cholangiocarcinoma: a review. Liver Int. 2005; 25: 704-716. (Pubitemid 41038651)
67. Ko KH, Kim NK, Yim DJ, Hong SP, Park PW, Rim KS, et al. Polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population. Anticancer Res. 2006; 26: 4229-4233. (Pubitemid 46031496)
68. Songserm N, Promthet S, Sithithaworn P, Pientong C, Ekalaksananan T, Chopjitt P, et al. Risk factors for cholangiocarcinoma in high-risk area of Thailand: role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms. Cancer Epidemiol. 2012; 36: e89-94.
69. Wadsworth CA, Dixon PH, Wong JH, Chapman MH, McKay SC, Sharif A, et al. Genetic factors in the pathogenesis of cholangiocarcinoma. Dig Dis. 2011; 29: 93-97.
70. Jongsuksuntigul P, Imsomboon T,. Opisthorchiasis control in Thailand. Acta Trop. 2003; 88: 229-232. (Pubitemid 37377818)
71. Kamsa-ard S, Wiangnon S, Suwanrungruang K, Promthet S, Khuntikeo N, Kamsa-ard S, et al. Trends in liver cancer incidence between 1985 and 2009, Khon Kaen, Thailand: cholangiocarcinoma. Asian Pac J Cancer Prev. 2011; 12: 2209-2213.